|
1
|
Königsberg R, Obermayr E, Bises G, Pfeiler
G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M and
Dittrich C: Detection of EpCAM positive and negative circulating
tumor cells in metastatic breast cancer patients. Acta Oncol.
50:700–710. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hart CD, Migliaccio I, Malorni L,
Guarducci C, Biganzoli L and Di Leo A: Challenges in the management
of advanced, ER-positive, HER2-negative breast cancer. Nat Rev Clin
Oncol. 12:541–552. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Saeki T, Tsuruo T, Sato W and Nishikawsa
K: Drug resistance in chemotherapy for breast cancer. Cancer
Chemother Pharmacol. 56 (Suppl 1):84–89. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jin Y, Zhang W, Wang H, Zhang Z, Chu C,
Liu X and Zou Q: EGFR/HER2 inhibitors effectively reduce the
malignant potential of MDR breast cancer evoked by P-gp substrates
in vitro and in vivo. Oncol Rep. 35:771–778. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang W, Zou L, Zhou D, Zhou Z, Tang F, Xu
Z and Liu X: Overexpression of ubiquitin carboxyl terminal
hydrolase-L1 enhances multidrug resistance and invasion/metastasis
in breast cancer by activating the MAPK/Erk signaling pathway. Mol
Carcinog. 55:1329–1342. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu LS, Chen L, Ding WX, Li K and Wu JJ:
Elevated expression of both MDR1 and MMP-2 genes in metastasized
lymph node of invasive ductal breast cancer. Eur Rev Med Pharmacol
Sci. 16:2037–2043. 2012.PubMed/NCBI
|
|
7
|
Matsuo K, Eno ML, Ahn EH, Shahzad MM, Im
DD, Rosenshein NB and Sood AK: Multidrug resistance gene (MDR-1)
and risk of brain metastasis in epithelial ovarian, fallopian tube,
and peritoneal cancer. Am J Clin Oncol. 34:488–493. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grünert S, Jechlinger M and Beug H:
Diverse cellular and molecular mechanisms contribute to epithelial
plasticity and metastasis. Nat Rev Mol Cell Biol. 4:657–665. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dave B, Mittal V, Tan NM and Chang JC:
Epithelial-mesenchymal transition, cancer stem cells and treatment
resistance. Breast Cancer Res. 14:2022012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y and Zhou BP: Epithelial-mesenchymal
transition - A Hallmark of breast cancer metastasis. Cancer Hallm.
1:38–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Makino T, Yamasaki M, Takeno A, Shirakawa
M, Miyata H, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T,
Matsuura N, et al: Cytokeratins 18 and 8 are poor prognostic
markers in patients with squamous cell carcinoma of the oesophagus.
Br J Cancer. 101:1298–1306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jung H, Kim B, Moon BI and Oh ES:
Cytokeratin 18 is necessary for initiation of TGF-β1-induced
epithelial-mesenchymal transition in breast epithelial cells. Mol
Cell Biochem. 423:21–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oshima RG, Baribault H and Caulín C:
Oncogenic regulation and function of keratins 8 and 18. Cancer
Metastasis Rev. 15:445–471. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schaafsma HE, Van Der Velden LA, Manni JJ,
Peters H, Link M, Rutter DJ and Ramaekers FC: Increased expression
of cytokeratins 8, 18 and vimentin in the invasion front of mucosal
squamous cell carcinoma. J Pathol. 170:77–86. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luan Y, Chao S, Ju ZY, Wang J, Xue X, Qi
TG, Cheng GH and Kong F: Therapeutic effects of baicalin on
monocrotaline-induced pulmonary arterial hypertension by inhibiting
inflammatory response. Int Immunopharmacol. 26:188–193. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Woelfle U, Sauter G, Santjer S, Brakenhoff
R and Pantel K: Down-regulated expression of cytokeratin 18
promotes progression of human breast cancer. Clin Cancer Res.
10:2670–2674. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schaller G, Fuchs I, Pritze W, Ebert A,
Herbst H, Pantel K, Weitzel H and Lengyel E: Elevated keratin 18
protein expression indicates a favorable prognosis in patients with
breast cancer. Clin Cancer Res. 2:1879–1885. 1996.PubMed/NCBI
|
|
21
|
Yoon HN, Yoon SY, Hong JH and Ku NO: A
mutation in keratin 18 that causes caspase-digestion resistance
protects homozygous transgenic mice from hepatic apoptosis and
injury. J Cell Sci. 130:2541–2550. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leifeld L, Kothe S, Söhl G, Hesse M,
Sauerbruch T, Magin TM and Spengler U: Keratin 18 provides
resistance to Fas-mediated liver failure in mice. Eur J Clin
Invest. 39:481–488. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi R, Zhu D, Wei Z, Fu N, Wang C, Liu L,
Zhang H, Liang Y, Xing J, Wang X, et al: Baicalein attenuates
monocrotaline-induced pulmonary arterial hypertension by inhibiting
endothelial-to-mesenchymal transition. Life Sci. 207:442–450. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi R, Wei Z, Zhu D, Fu N, Wang C, Yin S,
Liang Y, Xing J, Wang X and Wang Y: Baicalein attenuates
monocrotaline-induced pulmonary arterial hypertension by inhibiting
vascular remodeling in rats. Pulm Pharmacol Ther. 48:124–135. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song R, Song H, Liang Y, Yin D, Zhang H,
Zheng T, Wang J, Lu Z, Song X, Pei T, et al: Reciprocal activation
between ATPase inhibitory factor 1 and NF-κB drives hepatocellular
carcinoma angiogenesis and metastasis. Hepatology. 60:1659–1673.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barberà MJ, Puig I, Domínguez D,
Julien-Grille S, Guaita-Esteruelas S, Peiró S, Baulida J, Francí C,
Dedhar S, Larue L, et al: Regulation of Snail transcription during
epithelial to mesenchymal transition of tumor cells. Oncogene.
23:7345–7354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Allen JD, Brinkhuis RF, Wijnholds J and
Schinkel AH: The mouse Bcrp1/Mxr/Abcp gene: Amplification and
overexpression in cell lines selected for resistance to topotecan,
mitoxantrone, or doxorubicin. Cancer Res. 59:4237–4241.
1999.PubMed/NCBI
|
|
31
|
Doyle L and Ross DD: Multidrug resistance
mediated by the breast cancer resistance protein BCRP (ABCG2).
Oncogene. 22:7340–7358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Volk EL, Farley KM, Wu Y, Li F, Robey RW
and Schneider E: Overexpression of wild-type breast cancer
resistance protein mediates methotrexate resistance. Cancer Res.
62:5035–5040. 2002.PubMed/NCBI
|
|
33
|
Ingram WJ, Crowther LM, Little EB, Freeman
R, Harliwong I, Veleva D, Hassall TE, Remke M, Taylor MD and
Hallahan AR: ABC transporter activity linked to radiation
resistance and molecular subtype in pediatric medulloblastoma. Exp
Hematol Oncol. 2:262013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Golebiewska A, Brons NH, Bjerkvig R and
Niclou SP: Critical appraisal of the side population assay in stem
cell and cancer stem cell research. Cell Stem Cell. 8:136–147.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu C and Alman BA: Side population cells
in human cancers. Cancer Lett. 268:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Benderra Z, Faussat AM, Sayada L, Perrot
JY, Chaoui D, Marie JP and Legrand O: Breast cancer resistance
protein and P-glycoprotein in 149 adult acute myeloid leukemias.
Clin Cancer Res. 10:7896–7902. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Uggla B, Ståhl E, Wågsäter D, Paul C,
Karlsson MG, Sirsjö A and Tidefelt U: BCRP mRNA expression v.
clinical outcome in 40 adult AML patients. Leuk Res. 29:141–146.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nantajit D, Lin D and Li JJ: The network
of epithelial-mesenchymal transition: Potential new targets for
tumor resistance. J Cancer Res Clin Oncol. 141:1697–1713. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shintani Y, Okimura A, Sato K, Nakagiri T,
Kadota Y, Inoue M, Sawabata N, Minami M, Ikeda N, Kawahara K, et
al: Epithelial to mesenchymal transition is a determinant of
sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann
Thorac Surg. 92:1794–1804; discussion 1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Saxena M, Stephens MA, Pathak H and
Rangarajan A: Transcription factors that mediate
epithelial-mesenchymal transition lead to multidrug resistance by
upregulating ABC transporters. Cell Death Dis. 2:e1792011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fanelli MA, Montt-Guevara M, Diblasi AM,
Gago FE, Tello O, Cuello-Carrión FD, Callegari E, Bausero MA and
Ciocca DR: P-cadherin and beta-catenin are useful prognostic
markers in breast cancer patients; beta-catenin interacts with heat
shock protein Hsp27. Cell Stress Chaperones. 13:207–220. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Taube JH, Herschkowitz JI, Komurov K, Zhou
AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, et
al: Core epithelial-to-mesenchymal transition interactome
gene-expression signature is associated with claudin-low and
metaplastic breast cancer subtypes. Proc Natl Acad Sci USA.
107:15449–15454. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yin L, Castagnino P and Assoian RK: ABCG2
expression and side population abundance regulated by a
transforming growth factor beta-directed epithelial-mesenchymal
transition. Cancer Res. 68:800–807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bühler H and Schaller G: Transfection of
keratin 18 gene in human breast cancer cells causes induction of
adhesion proteins and dramatic regression of malignancy in vitro
and in vivo. Mol Cancer Res. 3:365–371. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kudo-Saito C, Shirako H, Takeuchi T and
Kawakami Y: Cancer metastasis is accelerated through
immunosuppression during Snail-induced EMT of cancer cells. Cancer
Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM
and Zhou BP: Stabilization of snail by NF-kappaB is required for
inflammation-induced cell migration and invasion. Cancer Cell.
15:416–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Min C, Eddy SF, Sherr DH and Sonenshein
GE: NF-kappaB and epithelial to mesenchymal transition of cancer. J
Cell Biochem. 104:733–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Takano M, Yamamoto C, Yamaguchi K, Kawami
M and Yumoto R: Analysis of TGF-β1- and drug-induced
epithelial-mesenchymal transition in cultured alveolar epithelial
cell line RLE/Abca3. Drug Metab Pharmacokinet. 30:111–118. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen WJ, Wang H, Tang Y, Liu CL, Li HL and
Li WT: Multidrug resistance in breast cancer cells during
epithelial-mesenchymal transition is modulated by breast cancer
resistant protein. Chin J Cancer. 29:151–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kwon CH, Park HJ, Choi JH, Lee JR, Kim HK,
Jo HJ, Kim HS, Oh N, Song GA and Park DY: Snail and serpinA1
promote tumor progression and predict prognosis in colorectal
cancer. Oncotarget. 6:20312–20326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yang Z, Zhang B, Liu B, Xie Y and Cao X:
Combined Runx2 and Snail overexpression is associated with a poor
prognosis in breast cancer. Tumour Biol. 36:4565–4573. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Huang T, Chen Z and Fang L: Curcumin
inhibits LPS-induced EMT through downregulation of NF-κB-Snail
signaling in breast cancer cells. Oncol Rep. 29:117–124. 2013.
View Article : Google Scholar : PubMed/NCBI
|
